Kiniksa Pharmaceuticals Stock Market Value
| KNSA Stock | USD 21.80 0.52 2.44% |
| Symbol | Kiniksa |
Kiniksa Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiniksa Pharmaceuticals. If investors know Kiniksa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiniksa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.5 | Earnings Share (0.12) | Revenue Per Share 5.415 | Quarterly Revenue Growth 0.674 | Return On Assets (0.03) |
The market value of Kiniksa Pharmaceuticals is measured differently than its book value, which is the value of Kiniksa that is recorded on the company's balance sheet. Investors also form their own opinion of Kiniksa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiniksa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiniksa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiniksa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiniksa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiniksa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiniksa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kiniksa Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kiniksa Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kiniksa Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Kiniksa Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Kiniksa Pharmaceuticals or generate 0.0% return on investment in Kiniksa Pharmaceuticals over 30 days. Kiniksa Pharmaceuticals is related to or competes with Nuvalent, Ventyx Biosciences, Arcellx, Cullinan Oncology, Day One, Structure Therapeutics, and Phathom Pharmaceuticals. Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercia... More
Kiniksa Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kiniksa Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kiniksa Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 20.0 | |||
| Value At Risk | (3.69) | |||
| Potential Upside | 3.88 |
Kiniksa Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kiniksa Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kiniksa Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Kiniksa Pharmaceuticals historical prices to predict the future Kiniksa Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.20) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kiniksa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kiniksa Pharmaceuticals Backtested Returns
Kiniksa Pharmaceuticals has Sharpe Ratio of -0.0869, which conveys that the firm had a -0.0869% return per unit of risk over the last 3 months. Kiniksa Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kiniksa Pharmaceuticals' Standard Deviation of 2.89, risk adjusted performance of (0.07), and Mean Deviation of 1.96 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.54, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kiniksa Pharmaceuticals will likely underperform. At this point, Kiniksa Pharmaceuticals has a negative expected return of -0.25%. Please make sure to verify Kiniksa Pharmaceuticals' potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Kiniksa Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.64 |
Good predictability
Kiniksa Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Kiniksa Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kiniksa Pharmaceuticals price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current Kiniksa Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.55 |
Kiniksa Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Kiniksa Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kiniksa Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Kiniksa Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Kiniksa Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kiniksa Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kiniksa Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kiniksa Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kiniksa Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Kiniksa Pharmaceuticals Lagged Returns
When evaluating Kiniksa Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kiniksa Pharmaceuticals stock have on its future price. Kiniksa Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kiniksa Pharmaceuticals autocorrelation shows the relationship between Kiniksa Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Kiniksa Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kiniksa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiniksa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiniksa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiniksa Pharmaceuticals Stock:Check out Kiniksa Pharmaceuticals Correlation, Kiniksa Pharmaceuticals Volatility and Kiniksa Pharmaceuticals Alpha and Beta module to complement your research on Kiniksa Pharmaceuticals. For information on how to trade Kiniksa Stock refer to our How to Trade Kiniksa Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Kiniksa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.